Maria Herrala1,2,3, Jopi J W Mikkonen4, Paula Pesonen5, Reijo Lappalainen4, Leo Tjäderhane3,6, Raija K Niemelä7, Hubertus Seitsalo8, Tuula Salo3,6, Sami Myllymaa4, Arja M Kullaa1,2,9. 1. Research Group of Oral Health Sciences, Faculty of Medicine, University of Oulu and Oulu University Hospital. 2. Institute of Dentistry, Faculty of Health Sciences, University of Eastern Finland. 3. Medical Research Center Oulu, University of Oulu and Oulu University Hospital. 4. SIB Labs and Department of Applied Physics, Faculty of Science and Forestry, University of Eastern Finland. 5. Infrastructure for Population Studies, Faculty of Medicine, University of Oulu. 6. Department of Oral and Maxillofacial Diseases, University of Helsinki and Helsinki University Hospital. 7. Department of Rheumatology, Oulu University Hospital. 8. Private practice. 9. Educational Dental Clinic, Kuopio University Hospital.
Abstract
PURPOSE: To investigate inter- and intra-individual variation in the levels and outputs (concentration multiplied by salivary flow rate) of salivary metabolites in patients with primary Sjögren's syndrome (pSS). METHODS: A total of 56 samples of stimulated saliva were collected from 14 female pSS patients during four laboratory visits within 20 weeks and analyzed using proton nuclear magnetic resonance spectroscopy. Single saliva samples from each of 15 controls were also analyzed. RESULTS: Among 21 quantified metabolites, choline was significantly elevated in the pSS patients at each time point (P ≤ 0.015), taurine at the last three time points (P ≤ 0.013), alanine at the last two time points (P ≤ 0.007) and glycine at the last time point (P = 0.005). Inter-individual variation in metabolite concentrations was generally larger among the patients than among the controls, and significantly large variations were observed for glycine (P ≤ 0.007, all time points), choline (P ≤ 0.033, three last time points) and alanine (P = 0.028, baseline). Metabolite output analysis showed that choline had the lowest intra-patient variation. CONCLUSION: In spite of considerable intra- and inter-individual variation, levels and outputs of specific metabolites in patients with pSS differ from those in controls, and may be potentially applicable as new biological markers for monitoring of the response to treatment.
PURPOSE: To investigate inter- and intra-individual variation in the levels and outputs (concentration multiplied by salivary flow rate) of salivary metabolites in patients with primary Sjögren's syndrome (pSS). METHODS: A total of 56 samples of stimulated saliva were collected from 14 female pSSpatients during four laboratory visits within 20 weeks and analyzed using proton nuclear magnetic resonance spectroscopy. Single saliva samples from each of 15 controls were also analyzed. RESULTS: Among 21 quantified metabolites, choline was significantly elevated in the pSSpatients at each time point (P ≤ 0.015), taurine at the last three time points (P ≤ 0.013), alanine at the last two time points (P ≤ 0.007) and glycine at the last time point (P = 0.005). Inter-individual variation in metabolite concentrations was generally larger among the patients than among the controls, and significantly large variations were observed for glycine (P ≤ 0.007, all time points), choline (P ≤ 0.033, three last time points) and alanine (P = 0.028, baseline). Metabolite output analysis showed that choline had the lowest intra-patient variation. CONCLUSION: In spite of considerable intra- and inter-individual variation, levels and outputs of specific metabolites in patients with pSS differ from those in controls, and may be potentially applicable as new biological markers for monitoring of the response to treatment.
Authors: Yangyang Cui; Hankun Zhang; Jia Zhu; Zhenhua Liao; Song Wang; Weiqiang Liu Journal: Int J Environ Res Public Health Date: 2022-03-30 Impact factor: 3.390